208 related articles for article (PubMed ID: 37035199)
1. Tim3 and PD-1 as a therapeutic and prognostic targets in colorectal cancer: Relationship with sidedness, clinicopathological parameters, and survival.
Mokhtari Z; Rezaei M; Sanei MH; Dehghanian A; Faghih Z; Heidari Z; Tavana S
Front Oncol; 2023; 13():1069696. PubMed ID: 37035199
[TBL] [Abstract][Full Text] [Related]
2. Impact of sidedness of colorectal cancer on tumor immunity.
Takasu C; Nishi M; Yoshikawa K; Tokunaga T; Kashihara H; Yoshimoto T; Shimada M
PLoS One; 2020; 15(10):e0240408. PubMed ID: 33045001
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance and prognostic role of LAG3 + tumor-infiltrating lymphocytes in colorectal cancer; relationship with sidedness.
Tavana S; Mokhtari Z; Sanei MH; Heidari Z; Dehghanian AR; Faghih Z; Rezaei M
Cancer Cell Int; 2023 Feb; 23(1):23. PubMed ID: 36765348
[TBL] [Abstract][Full Text] [Related]
4. Increased coexpression of PD-L1 and TIM3/TIGIT is associated with poor overall survival of patients with esophageal squamous cell carcinoma.
Wang P; Chen Y; Long Q; Li Q; Tian J; Liu T; Wu Y; Ding Z
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34625514
[TBL] [Abstract][Full Text] [Related]
5. Loss of survival advantage for deficient mismatch repair in patients with advanced colorectal cancer may be caused by changes in prognostic value of CD8+T cell.
Wang B; Li F; Guo L; Lu S; Ma J; Ma Y; Meng Y; Wang J; Zhou X; Fu W
World J Surg Oncol; 2020 Aug; 18(1):196. PubMed ID: 32767974
[TBL] [Abstract][Full Text] [Related]
6. IL8 derived from macrophages inhibits CD8
Zhao C; Wang D; Li Z; Zhang Z; Xu Y; Liu J; Lei Q; Han D; Huo Y; Liu S; Li L; Zhang Y
Int Immunopharmacol; 2023 Aug; 121():110457. PubMed ID: 37331296
[TBL] [Abstract][Full Text] [Related]
7. Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer.
He X; Peng Y; He G; Ye H; Liu L; Zhou Q; Shi J; Fu S; Wang J; Zhou Z; Li W
J Transl Med; 2023 Oct; 21(1):717. PubMed ID: 37828574
[TBL] [Abstract][Full Text] [Related]
8. Identification of an at-risk subpopulation with high immune infiltration based on the peroxisome pathway and TIM3 in colorectal cancer.
Yin J; Wang H; Hong Y; Ren A; Wang H; Liu L; Zhao Q
BMC Cancer; 2022 Jan; 22(1):44. PubMed ID: 34996408
[TBL] [Abstract][Full Text] [Related]
9. Presence of Tim3
Klapholz M; Drage MG; Srivastava A; Anderson AC
J Pathol; 2022 Jun; 257(2):186-197. PubMed ID: 35119692
[TBL] [Abstract][Full Text] [Related]
10. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Impact of PD-1 and Tim-3 Expression in Tumor Tissue in Stage I-III Colorectal Cancer.
Kuai W; Xu X; Yan J; Zhao W; Li Y; Wang B; Yuan N; Li Z; Jia Y
Biomed Res Int; 2020; 2020():5294043. PubMed ID: 32509862
[TBL] [Abstract][Full Text] [Related]
13. The Alteration of T-Cell Heterogeneity and PD-L1 Colocalization During dMMR Colorectal Cancer Progression Defined by Multiplex Immunohistochemistry.
Yan H; Li Y; Wang X; Qian J; Xu M; Peng J; Huang D
Front Oncol; 2022; 12():867658. PubMed ID: 35669431
[TBL] [Abstract][Full Text] [Related]
14. Association between Tim‑3 and Gal‑9 expression and gastric cancer prognosis.
Wang Y; Zhao E; Zhang Z; Zhao G; Cao H
Oncol Rep; 2018 Oct; 40(4):2115-2126. PubMed ID: 30106451
[TBL] [Abstract][Full Text] [Related]
15. CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer.
Peng QH; Wang CH; Chen HM; Zhang RX; Pan ZZ; Lu ZH; Wang GY; Yue X; Huang W; Liu RY
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33579737
[TBL] [Abstract][Full Text] [Related]
16. High endothelial venules proportion in tertiary lymphoid structure is a prognostic marker and correlated with anti-tumor immune microenvironment in colorectal cancer.
Zhan Z; Shi-Jin L; Yi-Ran Z; Zhi-Long L; Xiao-Xu Z; Hui D; Pan YL; Pan JH
Ann Med; 2023 Dec; 55(1):114-126. PubMed ID: 36503344
[TBL] [Abstract][Full Text] [Related]
17. Preoperative Tim‑3 expression on peripheral NK cells is correlated with pathologic TNM staging in colorectal cancer.
Wang Y; Sun J; Gao W; Song B; Shao Q; Zhao L; Zhang Y; Wang Q; Zhang Y; Qu X
Mol Med Rep; 2017 Jun; 15(6):3810-3818. PubMed ID: 28440449
[TBL] [Abstract][Full Text] [Related]
18. Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry.
Park Y; Seo AN; Koh J; Nam SK; Kwak Y; Ahn SH; Park DJ; Kim HH; Lee HS
Oncoimmunology; 2021; 10(1):1954761. PubMed ID: 34367732
[TBL] [Abstract][Full Text] [Related]
19. T cell exhaustion drives osteosarcoma pathogenesis.
Sun CY; Zhang Z; Tao L; Xu FF; Li HY; Zhang HY; Liu W
Ann Transl Med; 2021 Sep; 9(18):1447. PubMed ID: 34733999
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of T cell immunoglobulin and mucin-domain containing-3 expression in upper gastrointestinal tract tumors: A meta-analysis.
Yan JJ; Liu BB; Yang Y; Liu MR; Wang H; Deng ZQ; Zhang ZW
World J Gastrointest Oncol; 2023 Dec; 15(12):2212-2224. PubMed ID: 38173439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
